XML 25 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation
3 Months Ended
May 31, 2012
Compensation Related Costs, Share Based Payments  
Disclosure of Compensation Related Costs, Share-based Payments
Note 7.  Stock-Based Compensation
 
We have both an employee and director stock incentive plan, which are described more fully in Note 10 in our 2011 Annual Report on Form 10-K.  As of May 31, 2012, we had approximately 2,689,000 shares of common stock reserved for future issuance under the stock incentive plans.
 
Stock-based compensation cost is measured at the grant date based on the value of the award granted using the Black-Scholes option pricing model, and recognized over the period in which the award vests.  For stock awards no longer expected to vest, any previously recognized stock compensation expense is reversed in the period of termination.  The stock-based compensation expense has been allocated to the various categories of operating costs and expenses in a manner similar to the allocation of payroll expense as follows:
 
   
Three Months Ended
May 31,
  
Nine Months Ended
May 31,
 
   
2012
  
2011
  
2012
  
2011
 
              
Cost of sales
 $16,021  $16,442  $48,067  $21,062 
Research and development
  44,956   64,571   154,725   120,834 
Selling, general and administrative
  249,567   251,358   688,262   586,801 
                  
Total
 $310,544  $332,371  $891,054  $728,697 
 
During the nine months ended May 31, 2012, we granted employees 373,000 stock options at exercise prices ranging from $2.04 to $2.58 per share and with one third vesting each year for the next three years.  The estimated weighted average grant date fair value per share of these stock options was $1.31, and our weighted average assumptions used in the Black-Scholes valuation model to determine this estimated fair value are as follows:
 
 Expected volatility
69.93%
 Expected dividends0%
 Expected term 7.30 years
 Risk-free interest rate1.34%
   
Unrecognized stock-based compensation expense expected to be recognized over the estimated weighted-average amortization period of 1.34 years is approximately $2,144,000 as of May 31, 2012.
 
A summary of the time-based stock option awards as of May 31, 2012, and changes during the nine months then ended, is as follows:
   
Shares
  
Weighted-
Average
Exercise
Price
  
Weighted-
Average
Remaining
Contract Term
(Years)
  
Aggregate
Intrinsic
Value
 
              
Outstanding at August 31, 2011
  2,852,239  $3.74       
Granted
  373,000   2.24       
Exercised
  -   -     $- 
Forfeited or expired
  (52,000)  4.08        
                 
Outstanding at May 31, 2012
  3,173,239  $3.56   6.62  $80,491 
                  
Exercisable at May 31, 2012
  1,508,800  $4.00   5.63  $80,491 
    
The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value, based on our closing stock price of $1.61 as of May 31, 2012, which would have been received by the holders of in-the-money options had the option holders exercised their options as of that date.